Literature DB >> 1679336

Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.

M Kujacic1, K Svensson, L Löfberg, A Carlsson.   

Abstract

Previous work in this laboratory, as well as observations reported in the literature, indicate that the adrenal medulla contains dopamine (DA) receptors of the D-2 subtype, which among other things are capable of controlling the DA level in rat adrenal glands. To further characterize the DA receptors involved in the control of the adrenal DA level, the effects of 9 DA receptor agonists with various intrinsic activities were compared. After various periods of drug administration the rats were killed by decapitation and the DA content of the adrenal glands and the DOPAC content of the forebrain were measured by high-performance liquid chromatography with electrochemical detection. All the investigated DA receptors agonists caused an increase in adrenal DA level, although statistical significance was not reached in one case [(-)-HW 165]. Domperidone, a DA D-2 receptor antagonist which does not readily cross the blood brain barrier, blocked the DA-elevating effects of apomorphine, quinpirole, B-HT 920 and both enantiomers of 3-PPP. For the two ergolines terguride and SDZ 208-920 the blockade by domperidone was not complete, suggesting that their effects are mediated not only through DA, but also through other receptor systems. The dose of domperidone used (3 mg/kg) had but a marginal influence on brain DOPAC levels, supporting the almost exclusively peripheral effect of this agent. Our data indicate that the DA D-2 receptors which control the DA level in the adrenal medulla in rats, have characteristics similar to, though not identical with the autoreceptors in the forebrain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679336     DOI: 10.1007/bf01244970

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  16 in total

1.  Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland.

Authors:  M Schalling; A Dagerlind; M Goldstein; M Ehrlich; P Greengard; T Hökfelt
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

2.  B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.

Authors:  N E Andén; M Grabowska-Andén
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.

Authors:  N E Andén; M Grabowska-Andén
Journal:  Acta Physiol Scand       Date:  1987-09

4.  Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393.

Authors:  S Hjorth; A Carlsson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.

Authors:  N E Andén; H Nilsson; E Ros; U Thornström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-01

6.  Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

Authors:  P M Laduron; J E Leysen
Journal:  Biochem Pharmacol       Date:  1979-07-15       Impact factor: 5.858

Review 7.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

8.  Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.

Authors:  W Kehr
Journal:  Eur J Pharmacol       Date:  1984-01-13       Impact factor: 4.432

Review 9.  Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

10.  Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations.

Authors:  S Hjorth; D Clark; A Carlsson
Journal:  Life Sci       Date:  1985-08-19       Impact factor: 5.037

View more
  4 in total

1.  I. c. v. dopamine fails to alter adrenomedullary function in rats.

Authors:  M Kujacic; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1994

2.  Roles of dopaminergic d(1) and d(2) receptors in catecholamine release from the rat adrenal medulla.

Authors:  Young Joo Baek; Yoo Seong Seo; Dong Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-02-28       Impact factor: 2.016

3.  Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors.

Authors:  M Kujacic; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats.

Authors:  M Kujacic; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.